Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Biomedical Scientist Testing Nanoparticles as Early Cancer Detection Agent

24.10.2002


Shuming Nie holds a joint appointment at Georgia Tech and Emory University


Biomedical scientist Shuming Nie is testing the use of nanoparticles called quantum dots to dramatically improve clinical diagnostic tests for the early detection of cancer. The tiny particles glow and act as markers on cells and genes, giving scientists the ability to rapidly analyze biopsy tissue from cancer patients so that doctors can provide the most effective therapy available.

Nie, a chemist by training, is an associate professor in the Wallace H. Coulter Department of Biomedical Engineering – a joint department operated by the Georgia Institute of Technology (Georgia Tech) and Emory University – and director of cancer nanotechnology at Emory’s Winship Cancer Institute.

His research focuses on the field of nanotechnolgy, in which scientists build devices and materials one atom or molecule at a time, creating structures that take on new properties by virtue of their miniature size. The basic building block of nanotechnology is a nanoparticle, and a nanometer is one-billionth of a meter, or about 100,000 times smaller than the width of a human hair.



Nanoparticles take on special properties because of their small size. For example, if you break a piece of candy into two pieces, each piece will still be sweet, but if you continue to break the candy until you reach the nanometer scale, the smaller pieces will taste completely different and have different properties.

Until recently, nanotechnology was primarily based in electronics, manufacturing, supercomputers and data storage. However Nie predicted years ago in a paper published in Science that the first major breakthroughs in the field will be in biomedical applications, such as early disease detection, imaging and drug delivery.

“Electronics may be the field most likely to derive the greatest economic benefit from nanotechnology,” Nie said. “However, much of the benefit is unlikely to occur for another 10 to 20 years, whereas the biomedical applications of nanotechnology are very close to being realized.”

Nie was recently recruited from Indiana University as a Georgia Cancer Coalition Distinguished Scientist. While at Indiana, Nie and his colleagues constructed a nanoscale semiconductor crystal. Also called a quantum dot, this particle is made of semiconductors with a limited ability to conduct electricity.

Because quantum dots are so small, their electrons are compacted, causing them to emit light or to act as a fluorescent tag. Quantum dots can bond chemically to biological molecules, enabling them to trace specific proteins within cells. Nie calls them “bioconjugated nanoparticles”—small particles that are chemically linked to biological materials.

Nanoparticle probes can be used as contrast markers in magnetic resonance imaging (MRI), in positron emission tomography (PET) for in-vivo molecular imaging, or they can be used as fluorescent tracers in optical microscopy. These tags can trace specific proteins in cells for cancer diagnosis or monitor the effectiveness of drug therapy. Because the dots glow with bright, fluorescent colors, scientists hope they will improve the sensitivity of diagnostic tests for molecules that are difficult to detect, such as those in cancer cells, or even the AIDS virus, Nie said.

“Basically, it is a barcoding technology that can encode genes and proteins,” Nie said. He plans to use bioconjugated nanoparticles for early identification, quantification, and localization of gene sequences, proteins, infectious organisms, or genetic disorders.

Many of the practical applications of nanoparticles are based on the different colors they absorb or emit in the light spectrum as their sizes change. A piece of gold, for instance, appears yellow in color, but appears red at nanoscale size. Broken down even smaller, it could appear to be blue.

Using a spectrum of six colors, in addition to four more colors in the infrared spectrum, scientists are able to finely tune nanoparticles to carry out tracking tasks traditionally accomplished using organic dyes. Nanoparticles have characteristics that are more desirable than dyes, however. Dyes fade more quickly, they can be toxic to cells, and they cannot be used together because each dye requires a different light wavelength to be visible. Nanoparticles can be illuminated using just one laser beam.

Scientists only have to vary the size of quantum dots slightly and they glow brightly in one of 10 available colors. When different sized dots are embedded in tiny beads made of a polymer material, the color of the bead can be finely tuned. Theoretically, beads with tiny permutations of color could tag a million different proteins or genetic sequences in a process called “multiplexing.”

Nie acts as a senior consultant to Bioplex Corp., a company spun out of his lab’s research in Indiana and headed by Tom Petzinger, CEO. The company, which holds the exclusive license from Indiana University for the synthesis of multiplexing dyes for imaging and detection, was recently added to the roster of start-ups at EmTech Bio, a business incubator jointly run by Georgia Tech and Emory University. Bioplex Corporation is partially owned by Pittsburgh-based LaunchCyte.

Scientists, including Nie, are currently studying methods of linking quantum dots to medical drugs or other therapeutic agents to target cancer cells. These dots could serve as “smart bombs” to deliver a controlled amount of drug to a particular type of cell.

Nie is working with Emory University cancer urologist Lelund Chung to use bioconjugated quantum dots as molecular probes to rapidly analyze biopsy tissue from cancer patients. The nanoparticles would be able to profile a large number of genes and proteins simultaneously, allowing physicians to individualize cancer treatments based on the molecular differences in the cancers of various patients. Even when cells appear to be similar under the microscope, their genes and proteins may be decidedly different, which explains why cancer patients with apparently similar cancers sometimes respond differently to the same treatment.

Nie and his colleagues are working on methods to deliver nanoparticles into specific kinds of tissues and cells—a process that would make cancer therapy more selective. Using near-infrared imaging technology, they are monitoring the migration of the particles within cells.

Nie is also working with tissue engineers at Georgia Tech and Emory to study the use of nanoparticles to construct new materials that could be used as improved implants for damaged tissue, such as bone, cartilage, or skin. Bio-nanomaterials provide new opportunities in cell and tissue engineering, such as cell growth/differentiation, tissue scaffolding, and controlled release of multiple growth factors.

Larry Bowie | EurekAlert!
Further information:
http://www.gatech.edu/news-room/
http://gtresearchnews.gatech.edu/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

New bioimaging technique is fast and economical

21.08.2017 | Medical Engineering

Silk could improve sensitivity, flexibility of wearable body sensors

21.08.2017 | Materials Sciences

On the way to developing a new active ingredient against chronic infections

21.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>